Disease exacerbation of multiple sclerosis is characterized by loss of terminally differentiated autoregulatory CD8+ T cells.

[1]  Nitin J. Karandikar,et al.  The Disease-Ameliorating Function of Autoregulatory CD8 T Cells Is Mediated by Targeting of Encephalitogenic CD4 T Cells in Experimental Autoimmune Encephalomyelitis , 2013, The Journal of Immunology.

[2]  Nitin J. Karandikar,et al.  CD8+ T Cells Are Required For Glatiramer Acetate Therapy in Autoimmune Demyelinating Disease , 2013, PloS one.

[3]  Chester Ni,et al.  In Active Relapsing-Remitting Multiple Sclerosis, Effector T Cell Resistance to Adaptive Tregs Involves IL-6–Mediated Signaling , 2013, Science Translational Medicine.

[4]  P. Durrenberger,et al.  Increased HLA-E expression in white matter lesions in multiple sclerosis , 2012, Immunology.

[5]  D. Hafler,et al.  Regulatory T cells in the central nervous system , 2012, Immunological reviews.

[6]  Jeffrey A. Cohen,et al.  Multiple sclerosis: new insights in pathogenesis and novel therapeutics. , 2012, Annual review of medicine.

[7]  L. Davis,et al.  IL-12 selectively programs effector pathways that are stably expressed in human CD8+ effector memory T cells in vivo. , 2011, Blood.

[8]  S. Burrows,et al.  CD8 T cell deficiency impairs control of Epstein–Barr virus and worsens with age in multiple sclerosis , 2011, Journal of Neurology, Neurosurgery & Psychiatry.

[9]  Nitin J. Karandikar,et al.  Neuroantigen-specific CD8+ regulatory T-cell function is deficient during acute exacerbation of multiple sclerosis. , 2011, Journal of autoimmunity.

[10]  G. Filaci,et al.  CD8+ T regulatory/suppressor cells and their relationships with autoreactivity and autoimmunity , 2011, Autoimmunity.

[11]  D. Reen,et al.  Neonatal CD8+ T-cell differentiation is dependent on interleukin-12. , 2010, Human immunology.

[12]  Nitin J. Karandikar,et al.  Immune regulatory CNS-reactive CD8+T cells in experimental autoimmune encephalomyelitis. , 2010, Journal of autoimmunity.

[13]  J. Lieberman,et al.  Isolation of Cytotoxic T Cell and NK Granules and Purification of Their Effector Proteins , 2010, Current protocols in cell biology.

[14]  K. Venken,et al.  Disturbed regulatory T cell homeostasis in multiple sclerosis. , 2010, Trends in molecular medicine.

[15]  J. Correale,et al.  Role of CD8+ CD25+ Foxp3+ regulatory T cells in multiple sclerosis , 2009, Annals of neurology.

[16]  C. Weyand,et al.  Treating autoimmune disease by targeting CD8+ T suppressor cells , 2009, Expert opinion on biological therapy.

[17]  Yan Li,et al.  CD8+ regulatory T cells are responsible for GAD‐IgG gene‐transferred tolerance induction in NOD mice , 2009, Immunology.

[18]  C. Megli,et al.  Chimeric NKG2D receptor-expressing T cells as an immunotherapy for multiple myeloma. , 2008, Experimental hematology.

[19]  D. Vignali,et al.  How regulatory T cells work , 2008, Nature Reviews Immunology.

[20]  Vipin Kumar,et al.  Revival of CD8+ Treg-mediated suppression. , 2008, Trends in immunology.

[21]  B. Trapp,et al.  Multiple sclerosis: an immune or neurodegenerative disorder? , 2008, Annual review of neuroscience.

[22]  K. Venken,et al.  Natural Naive CD4+CD25+CD127low Regulatory T Cell (Treg) Development and Function Are Disturbed in Multiple Sclerosis Patients: Recovery of Memory Treg Homeostasis during Disease Progression1 , 2008, The Journal of Immunology.

[23]  J. Correale,et al.  Isolation and characterization of CD8+ regulatory T cells in multiple sclerosis , 2008, Journal of Neuroimmunology.

[24]  K. Isobe,et al.  Essential Role of CD8+CD122+ Regulatory T Cells in the Recovery from Experimental Autoimmune Encephalomyelitis1 , 2008, The Journal of Immunology.

[25]  Roland Martin,et al.  Multiple sclerosis: a complicated picture of autoimmunity , 2007, Nature Immunology.

[26]  Ningli Li,et al.  Role of IFN-γ in induction of Foxp3 and conversion of CD4+ CD25– T cells to CD4+ Tregs , 2006 .

[27]  Nitin J. Karandikar,et al.  CD28−CD57+ T cells predominate in CD8 responses to glatiramer acetate , 2006, Journal of Neuroimmunology.

[28]  O. Kantarci,et al.  Epidemiology and natural history of multiple sclerosis: new insights , 2006, Current opinion in neurology.

[29]  Nitin J. Karandikar,et al.  Therapeutic Induction of Regulatory, Cytotoxic CD8+ T Cells in Multiple Sclerosis1 , 2006, The Journal of Immunology.

[30]  J. Nattermann,et al.  Comparative study of NK cell-mediated cytotoxicity using radioactive and flow cytometric cytotoxicity assays. , 2005, Journal of immunological methods.

[31]  B. Bisikirska,et al.  TCR stimulation with modified anti-CD3 mAb expands CD8+ T cell population and induces CD8+CD25+ Tregs. , 2005, The Journal of clinical investigation.

[32]  Y. Kang,et al.  Cell-Based Immunotherapy with Suppressor CD8+ T Cells in Rheumatoid Arthritis1 , 2005, The Journal of Immunology.

[33]  Hye-young Park,et al.  4-1BB-mediated immunotherapy of rheumatoid arthritis , 2004, Nature Medicine.

[34]  Nitin J. Karandikar,et al.  High prevalence of autoreactive, neuroantigen-specific CD8+ T cells in multiple sclerosis revealed by novel flow cytometric assay. , 2004, Blood.

[35]  Clare Baecher-Allan,et al.  Loss of Functional Suppression by CD4+CD25+ Regulatory T Cells in Patients with Multiple Sclerosis , 2004, The Journal of experimental medicine.

[36]  C. Sousa.  Faculty Opinions recommendation of Signal 3 determines tolerance versus full activation of naive CD8 T cells: dissociating proliferation and development of effector function. , 2003 .

[37]  Hans Lassmann,et al.  Clonal Expansions of Cd8+ T Cells Dominate the T Cell Infiltrate in Active Multiple Sclerosis Lesions as Shown by Micromanipulation and Single Cell Polymerase Chain Reaction , 2000, The Journal of experimental medicine.

[38]  P. Klimiuk,et al.  IL-16 as an anti-inflammatory cytokine in rheumatoid synovitis. , 1999, Journal of immunology.

[39]  J. Antel,et al.  MHC class I-restricted lysis of human oligodendrocytes by myelin basic protein peptide-specific CD8 T lymphocytes. , 1998, Journal of immunology.

[40]  H. Weiner,et al.  Inhibition of T cell responses by activated human CD8+ T cells is mediated by interferon-gamma and is defective in chronic progressive multiple sclerosis. , 1995, The Journal of clinical investigation.

[41]  Hong Jiang,et al.  Role of CD8+ T Cells in Murine Experimental Allergic Encephalomyelitis , 1992, Science.

[42]  T. Mak,et al.  Less Mortality but More Relapses in Experimental Allergic Encephalomyelitis in CD8-/- Mice , 1992, Science.

[43]  J. Antel,et al.  Defective suppressor cell function mediated by T8+ cell lines from patients with progressive multiple sclerosis. , 1986, Journal of immunology.

[44]  Bradford Z. Mahon,et al.  Category-Specific Organization in the Human Brain Does Not Require Visual Experience , 2009, Neuron.

[45]  X. Chen,et al.  Role of IFN-gamma in induction of Foxp3 and conversion of CD4+ CD25- T cells to CD4+ Tregs. , 2006, The Journal of clinical investigation.

[46]  A. Perl,et al.  CD8 T Cell-Mediated HLA-A*0201-Restricted Cytotoxicity to Transaldolase Peptide 168–176 in Patients with Multiple Sclerosis , 2005 .

[47]  J. Mussini,et al.  [Immunology of multiple sclerosis]. , 1982, La semaine des hopitaux : organe fonde par l'Association d'enseignement medical des hopitaux de Paris.

[48]  W. L. Benedict,et al.  Multiple Sclerosis , 2007, Journal - Michigan State Medical Society.